Abstract
1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have